Kidney journal to retract stem cell paper for duplicated and doctored images

kidney intKidney International is in the process of retracting a stem cell paper containing plagiarized images, Retraction Watch has learned.

Here’s the notice that will appear for “Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin“: Continue reading Kidney journal to retract stem cell paper for duplicated and doctored images

Shigeaki Kato up to 28 retractions, with three papers cited nearly 700 times

Shigeaki Kato
Shigeaki Kato

Former University of Tokyo researcher Shigeaki Kato has notched his 26th, 27th, and 28th retractions, all in Nature Cell Biology. The three papers have been cited a total of 677 times.

Here’s the notice for “DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs:” Continue reading Shigeaki Kato up to 28 retractions, with three papers cited nearly 700 times

Fudged figures sink breast cancer paper

oncogeneA prestigious cancer journal has pulled an article over “concerns” regarding some of the figures, which PubPeer commenters had tagged as suspect.

A few weeks after the paper was published on June 9, comments on PubPeer began accumulating. Commenters called out both potentially manipulated and repeated images. The exact timeline is not clear, because Oncogene does not list a date on the retraction notice, but by August 29 the paper had been retracted.

Here’s the notice for “IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer,” by researchers at Shanghai Jiaotong University School of Medicine and Ruijin Hospital, both in Shanghai, China, and the University of Michigan: Continue reading Fudged figures sink breast cancer paper

First author blamed for retraction in prestigious medical journal

jemcoverThe authors of a Journal of Experimental Medicine have retracted it, blaming the first author for data and figure manipulation.

The paper, “The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells,” was initially published in September 2011 and has been cited 25 times, according to Thomson Scientific’s Web of Knowledge. First author Jiyeon Kim was an MD-PhD candidate at the University of Pennsylvania until this year, according to a LinkedIn profile.

Here’s the notice: Continue reading First author blamed for retraction in prestigious medical journal

Another Nature stem cell paper is retracted

nature 73014Another stem cell paper has been retracted from Nature, this one a highly cited 2008 study that had already been the subject of what the journal’s news section called a “furore” in 2010.

According to that 2010 news story:

The researchers behind the original work1, led by Thomas Skutella of the University of Tübingen, reported using cells from adult human testes to create pluripotent stem cells with similar properties to embryonic stem cells.

But a 2010 Brief Communication Arising called those findings into question. And now, the authors have retracted the paper. Here’s the notice for “Generation of pluripotent stem cells from adult human testis:” Continue reading Another Nature stem cell paper is retracted

Incorrect analysis leads to Nature’s sixth retraction in 2014

nature 714In what seems to be an example of researchers swiftly and transparently correcting the literature, and acknowledging errors, a pair of scientists have retracted a 2013 paper from Nature.

Here’s the retraction notice for “Genomic organization of human transcription initiation complexes,” by Bryan Venters and Frank Pugh: Continue reading Incorrect analysis leads to Nature’s sixth retraction in 2014

Second Nature paper by researcher found to have violated academic integrity retracted

dhonukshe
Pankaj Dhonukshe

A second Nature paper co-authored by Pankaj Dhonukshe, formerly of Utrecht University and VIB Ghent, has been retracted.

Here’s the notice for “Generation of cell polarity in plants links endocytosis, auxin distribution and cell fate decisions:” Continue reading Second Nature paper by researcher found to have violated academic integrity retracted

STAP stem cell papers officially retracted as Nature argues peer review couldn’t have detected fatal problems

nature 714A significant chapter of the nearly six-month saga of the STAP stem cell controversy has come to an end, with Nature running retraction notices for the two papers involved. The journal has also published an editorial about the case that’s worth a read.

The retractions for “Bidirectional developmental potential in reprogrammed cells with acquired pluripotency” and “Stimulus-triggered fate conversion of somatic cells into pluripotency” both read: Continue reading STAP stem cell papers officially retracted as Nature argues peer review couldn’t have detected fatal problems

Geneticist retracting four papers for “significant problems”

jbc 620Benjamin Barré, a genetics researcher who recently set up his own group at the University of Angers, is retracting four papers he worked on as a graduate student and postdoc.

Neil Perkins, in whose lab Barré was a postdoc, and Olivier Coqueret, in whose lab he did his PhD, tell Retraction Watch: Continue reading Geneticist retracting four papers for “significant problems”

Researchers retract breast cancer study after realizing they were using the wrong antibody

br j cancerA group of researchers at Istanbul University has swiftly retracted a paper they published in March in the British Journal of Cancer once it became clear that they were using the wrong antibody.

Here’s the notice for “Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies:” Continue reading Researchers retract breast cancer study after realizing they were using the wrong antibody